Remove tag prescribing
article thumbnail

Grand Rounds July 14, 2023: Lessons From the COORDINATE-Diabetes Trial (Christopher B. Granger, MD; Neha J. Pagidipati, MD, MPH)

Rethinking Clinical Trials

of the patients ended up being prescribed all 3 therapies, and 37.9% of patients were prescribed all 3 therapies across the intervention sites. An important aspect of the intervention was regular phone calls and check-ins to patients prescribed the therapies to ensure they were taking the prescriptions. Granger, MD; Neha J.

Trials 130
article thumbnail

Grand Rounds April 7, 2023: A Nudge Towards Cardiovascular Health: Incorporating Insights From Behavioral Science to Improve Cardiovascular Care Delivery (Srinath Adusumalli, MD, MSHP, MBMI, FACC)

Rethinking Clinical Trials

The PRESCRIBE trial revealed the value of active choice as well as peer decision-making to prompt decision-making. Implementing the nudge tool within the Penn Medicine revealed several positive impacts, including referral rates increasing significantly via the implementation of a default pathway.

Medicine 100
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Jolly Good/Teijin Pharma develop VR digital therapeutics for depression

pharmaphorum

The initiative was supported by grants from UCB and Pfizer and provided health information in the form of immersive experiences aimed at patients prescribed biologic drugs to treat the disease. The company halted development before it eventually sold its digital health unit back to Eric Careel, co-founder of Withings, the following year.

article thumbnail

Grand Rounds March 1, 2024: Effect of an Intensive Food-As-Medicine Program on Health and Health Care Use: Evidence from a Randomized Clinical Trial (Joseph Doyle, PhD)

Rethinking Clinical Trials

For the intervention in this Food-as-Medicine trial, participants with diabetes were prescribed 10 meals/week for participants and their families that they could fill at the program’s clinic. Food-as-Medicine observational studies have had a large correlation with improved health. From a researcher standpoint, we need more information.

article thumbnail

The FDA and Aduhelm: WTF?

World of DTC Marketing

SKIMMERS SUMMARY: Jefferies analysts found doctors have shown strong interest in prescribing Aduhelm for about 35% of early-stage Alzheimer’s patients with mild cognitive impairment after surveying 50 U.S. Not to mention the $56,000 annual price tag. neurologists or psychiatrists currently treating about 12,000 Alzheimer’s patients.

Drugs 218
article thumbnail

Grand Rounds September 29, 2023: Navigating the Use of Patient-Reported Outcomes in Research and Practice: The PROTEUS Consortium (Claire Snyder, PhD; Norah Crossnohere, PhD; Anne Schuster, PhD)

Rethinking Clinical Trials

Some of the discussion included insurance coverage where PRO monitoring is included with a prescribed treatment plan. -Can you elaborate on the incentives and marketing recommendation from the Underserved Advisory Group? There was discussion about paying patients and patient advocates for the time they spend advocating for PROs.

article thumbnail

A broad range of unmet needs remains in the immuno-oncology space

Pharmaceutical Technology

High-prescribing physicians surveyed by GlobalData across eight major markets (8MM: US, France, Germany, Italy, Spain, UK, Japan, and China) identified a broad range of unmet needs in the IO space (see Figure 1). Despite the significant advances that have been made in the IO field, a huge level of unmet need remains.